HPS Pharmacies wish to give notice that Aspen Pharmacare Australia Pty Ltd are currently experiencing an interruption to the supply of:
|Form||Powder for injection|
This supply interruption of Alkeran® (melphalan) injection is due to a global shortage of the raw ingredient, and may continue until February 2015.
Alkeran® is the only brand of melphalan available in Australia, and remaining supplies are restricted to facilitate distribution to patients most at need. HPS Pharmacies will manage its remaining stocks to maintain continuity of therapy where possible. Medical staff are advised to review treatment plans in order to minimise demand during this time
This notice does not apply to Alkeran® (melphalan) tablets 2mg, Aust R. 81543 of which Aspen Pharmacare Australia hold ample supply.
Please retain this notice in a prominent position, including in other related business units as a reminder for all staff members until supply returns to normal.
Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies, or Aspen Pharmacare Australia on 1300 659 646.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.